NCT01107587View on ClinicalTrials.gov

Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

April 13, 2010

Primary Completion Date

June 28, 2010

Study Completion Date

June 28, 2010

Conditions
Infections, Rotavirus
Interventions
BIOLOGICAL

GSK Biologicals' human rotavirus vaccine 444563

Oral, two doses.

BIOLOGICAL

Placebo

Oral, two doses.

Trial Locations (1)

545200

GSK Investigational Site, Liucheng County

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01107587 - Study to Assess the Safety of GSK Biologicals' Liquid Human Rotavirus Vaccine in Healthy Infants | Biotech Hunter | Biotech Hunter